Literature DB >> 648806

Specific cancer immunotherapy adjunctive to surgery for advanced gastric cancer: a report of six long term survivors.

Y Ishikawa, M Fukushima, S Machida, H Kakuta, T Nishikawa, S Fukuda.   

Abstract

In order to improve the results with non-curatively resected advanced gastric cancer, we have tried specific cancer immunotherapy adjunctive to surgery. In this article, six long term survivors (median 6.2 years) are reported.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 648806     DOI： 10.1007/BF02774155

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN： 0435-1339


  7 in total

1.  ISOLATION AND PURIFICATION OF UNDEGRADED RIBONUCLEIC ACIDS.

Authors:  R K RALPH; A R BELLAMY
Journal:  Biochim Biophys Acta       Date:  1964-05-18

2.  Immune RNA in the immunotherapy of cancer.

Authors:  Y H Pilch; D Fritze; D H Kern
Journal:  Med Clin North Am       Date:  1976-05       Impact factor: 5.456

3.  Proceedings: Immunotherapy of malignant disease: the use of viable sensitized lymphocytes or transfer factor prepared from sensitized lymphocytes.

Authors:  E T Krementz; P W Mansell; M O Hornung; M S Samuels; C A Sutherland; E N Benes
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

4.  A new method of active immunisation to autologous human tumour tissue.

Authors:  P L Wolf; J Vazquez; N P Czajkowski; M Rosenblatt
Journal:  Lancet       Date:  1967-10-28       Impact factor: 79.321

5.  Passive transfer of the resistance to tumor with RNA.

Authors:  M Fukushima; S Machida; A Hokama; M Kojika; T Nishikawa
Journal:  Tohoku J Exp Med       Date:  1974-02       Impact factor: 1.848

6.  The general rules for The gastric cancer study in surgery.

Authors: 
Journal:  Jpn J Surg       Date:  1973-03

7.  Passive transfer of tumor-specific resistance to methylcholanthrene-induced sarcomas in rats.

Authors:  Y Ishikawa; M Fukushima; T Sato; M Komaba; H Yagihashi
Journal:  Tohoku J Exp Med       Date:  1971-02       Impact factor: 1.848
  7 in total
  2 in total

1.  A follow-up study on chemoimmunotherapy (5-fluorouracil and BCG) in advanced gastric cancer.

Authors:  T Popiela; M Zembala; J Oszacki; W Jedrychowski
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

2.  Specific immunotherapy for non-curatively resected gastric cancer.

Authors:  Y Ishikawa; H Kakuta; M Fukushima; S Machida; S Fukuda
Journal:  Jpn J Surg       Date:  1979-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.